HLA-G and neoplasm: Whereas, HLA-G seems to help tumor cells to escape from immunosurveillance by directly interacting with inhibitory receptors that halt innate and adaptive immune cells, Qa-2 appears to activate NK and CD8+ CTLs to reject tumors.